For: | Muengtaweepongsa S, Panpattanakul V. Is medical management useful in Moyamoya disease? World J Clin Cases 2024; 12(3): 466-473 [PMID: 38322475 DOI: 10.12998/wjcc.v12.i3.466] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v12/i3/466.htm |
Number | Citing Articles |
1 |
Chaofan Zeng, Haoyuan Chen, Jie Liu, Youyuan Bao, Xudong Sun, Fanbo Meng, Yimeng Xue, Yunhao Cui, Qianjun Zhao, Jing Zhang, Hao Li, Dong Zhang, Rong Wang, Yan Zhang, Guojun Zhang, Jizong Zhao, Qian Zhang. Unraveling the Dyslipidemic Landscape in Moyamoya Disease: OxLDL as a Key Biomarker. CNS Neuroscience & Therapeutics 2025; 31(5) doi: 10.1111/cns.70441
|
2 |
Jinpeng Wu, Yifan Xu, Chonghui Zhang, Cuiping Mu, Le Yu, Haowen Xu, Chao Wang, Zhenwen Cui. Development and validation of a predictive model for perioperative low-density lipoprotein as a risk factor for postoperative cerebral infarction in Moyamoya disease. Frontiers in Neurology 2025; 16 doi: 10.3389/fneur.2025.1602006
|